Viewing Study NCT04000594


Ignite Creation Date: 2025-12-25 @ 1:34 AM
Ignite Modification Date: 2026-01-23 @ 5:51 AM
Study NCT ID: NCT04000594
Status: COMPLETED
Last Update Posted: 2024-10-03
First Post: 2019-06-26
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Investigate the Pharmacokinetics and Pharmacodynamics of RO7234292 (RG6042) in CSF and Plasma, and Safety and Tolerability Following Intrathecal Administration in Patients With Huntington's Disease
Sponsor: Hoffmann-La Roche
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: BP40410
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators